Studies in mouse models of DS indicate that there could be a “point of no return” after which the transcriptome, proteome, and metabolome are altered in such a way that upregulation of SCN1A alone could no longer reverse these processes (Miljanovic and others 2021a, 2021b). The gene discussed is SCN1A; the disease is Dravet syndrome.